ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1546

Efficacy and Safety of Corticosteroids in Rheumatoid Arthritis: Systematic Literature Review and Practical Recommendations

Raimon Sanmartí1, Jesús Tornero Molina2, Francisco Javier Narváez3, Alejandro Muñoz4, Elena Garmendia5, Ana M. Ortiz Garcia6, Miguel A. Abad7, Patricia Moya8, Maria Lourdes Mateo9, Delia Reina10, Juan Salvatierra Osorio11, Sergio Rodriguez12, Ana Rubial Escribano13, Natalia Palmou-Fontana14 and Jaime Calvo-Alén15, 1Rheumatology Service, Hospital Clínic de Barcelona, Barcelona, Spain, 2Rheumatology Unit, Hospital de Guadalajara, Guadalajara, Spain, 3Rheumatology Department, Hospital Universitario de Bellvitge, Idibell, Barcelona, Spain, 4Rheumatology, Hospital Universitario Virgen del Rocío, Sevilla, Spain, 5Rheumatology, Hospital Universitario Cruces. Barakaldo. Spain, Barakaldo, Spain, 6Rheumatology, Rheumatology Service, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain, 7FEA Reumatología, Hospital Virgen del Puerto, Cáceres, Spain, 8Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 9Rheumatology, Hospital Germans Trias i Pujol, Badalona, Spain, 10Rheumatology, Hospital Moises Broggi, Sant Joan Despí, Spain, 11Complejo Hospitalario Universitario de Granada, Granada, Spain, 12Rheumatology, Hospital Universitario Virgen de Valme, Sevilla, Spain, 13Rheumatology, Hospital Alfredo Espinosa, Urduliz, Spain, 14Hospital Universitario Marqués de Valdecilla, IDIVAL. Universidad of Cantabria, Santander, Spain, 15Rheumatology Department, Hospital Universitario Araba. Vitoria-Gasteiz, Alava, Spain

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Effective, practice guidelines, Rheumatoid arthritis (RA), safety and steroids

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Rheumatoid Arthritis – Treatments Poster II: PROs, Safety and Comorbidity

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Corticosteroids are effective in rheumatoid arthritis (RA) patients but their adverse events limit their use. The aim of this study was to: 1) To systematically and critically review the evidence on the characteristics, efficacy and safety of corticosteroids in RA; 2) To generate practical recommendations on its use.

Methods:

We performed sensitive systematic literature searches in Medline and Cochrane (up to September 2017), screened EULAR and American College of Rheumatology meeting-abstracts. An expert librarian designed the strategies that included Mesh and text word terms. The search was limited to human RA, adults and the English and Spanish language. The inclusion criteria were as follow: 1) RA patients on corticosteroids; 2) Placebo and an active comparator were accepted as comparators; 3) Articles including typical efficacy and safety variables such as pain, DAS-28, radiographic progression or the infections rate; 4) Only meta-analyses, systematic reviews and clinical trials were selected. Two reviewers screened the titles and abstracts of the retrieved articles independently. They also collected the data from the studies included by using ad hoc standard forms. All collection was double by article and independent. Subsequently, a secondary manual search of the bibliography of the articles that were finally included was performed. Evidence tables were produced. The quality was evaluated with Jadad scale. In a nominal group meeting, based on their results, a panel of experts discusses this evidence and generated practical recommendations. The level of evidence and grade of recommendation was assessed according to the Center for Evidence Based Medicine de Oxford.

Results:

A total of 47 articles were included. Corticosteroids in combination with DMARDs help control disease activity and radiographic progression, especially in the short-medium term and in early RA. Corticosteroids can also improve function and pain. Different types and routes of administration are effective, but there is not a standardized scheme (initial dose, de-escalation and duration of treatment with corticosteroids) superior to others. Adverse events when using corticosteroids are very frequent, dose-dependent although most are mild. Seven recommendations were generated on the use and risk management of corticosteroids (see table).

Conclusion:

These recommendations aim to resolve some common clinical questions and facilitate decision-making with the use of corticosteroids in RA.

#

Recommendations

1

In patients with early RA, treatment with corticosteroids in combination with synthetic DMARDs is recommended (NE 1b; GR A)

2

In established RAs it is recommended to individualize the use of corticosteroids as a symptomatic treatment (NE 5; GR D)

3

Corticosteroids are recommended as bridging therapy in early RA, using low doses (≤ 7.5 mg/day of prednisone or equivalent), or medium doses (30 mg/day) following a rapid tapering scheme (NE 1b; GR A)

4

In patients with RA it is recommended to use the lowest effective dose of corticosteroids and to stop them as soon is possible (NE 1b; GR B)

5

When using corticosteroids in patients with RA, it is recommended to rule out comorbidities and risk of infection before their prescription (NE 5; GR D)

6

If corticosteroids are prescribed in the medium to long term, in patients with RA, close monitoring of cardiovascular risk factors and bone mineral density is recommended (NE 5; GR D)

7

If corticoids are prescribed in the medium to long term, in patients with RA, the prophylaxis of osteoporosis induced by corticosteroids is recommended (according to the recommendations of the international guidelines) (NE 5; GR D)


Disclosure: R. Sanmartí, None; J. Tornero Molina, None; F. J. Narváez, None; A. Muñoz, None; E. Garmendia, None; A. M. Ortiz Garcia, None; M. A. Abad, None; P. Moya, None; M. L. Mateo, None; D. Reina, None; J. Salvatierra Osorio, None; S. Rodriguez, None; A. Rubial Escribano, None; N. Palmou-Fontana, None; J. Calvo-Alén, None.

To cite this abstract in AMA style:

Sanmartí R, Tornero Molina J, Narváez FJ, Muñoz A, Garmendia E, Ortiz Garcia AM, Abad MA, Moya P, Mateo ML, Reina D, Salvatierra Osorio J, Rodriguez S, Rubial Escribano A, Palmou-Fontana N, Calvo-Alén J. Efficacy and Safety of Corticosteroids in Rheumatoid Arthritis: Systematic Literature Review and Practical Recommendations [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/efficacy-and-safety-of-corticosteroids-in-rheumatoid-arthritis-systematic-literature-review-and-practical-recommendations/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/efficacy-and-safety-of-corticosteroids-in-rheumatoid-arthritis-systematic-literature-review-and-practical-recommendations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology